Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
2023 · Liver Cancer · 404 citations
https://doi.org/10.1159/000530495
Z
Zheng Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
484
Papers
12.8K
Citations
53
h-index
193
i10-index
Zheng Wang is an academic researcher from Beijing University of Chinese Medicine. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Lung Cancer Treatments and Mutations & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 53, co-authored 412 publications.
ORCID: 0000-0003-4519-0795Papers by this author
worksAndrogen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
2018 · Nature Communications · 223 citations
https://doi.org/10.1038/s41467-018-06177-2
IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma
2011 · Molecular Cancer · 221 citations
https://doi.org/10.1186/1476-4598-10-150
Genomic <i>ERBB2</i> / <i>ERBB3</i> mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis
2018 · Gut · 199 citations
https://doi.org/10.1136/gutjnl-2018-316039
Advances and Prospect of Nanotechnology in Stem Cells
2009 · Nanoscale Research Letters · 107 citations
https://doi.org/10.1007/s11671-009-9292-z
Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma
2020 · Journal of Translational Medicine · 107 citations
https://doi.org/10.1186/s12967-020-02255-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat